Tolterodine Tartrate Extended-Release Capsules
Item Name Code (INC) 67495
![]() |
Additional Information for Tolterodine Tartrate Extended-Release Capsules
Tolterodine Tartrate Extended-Release Capsules are a type of medication that falls under the supply class Drugs And Biologicals in the supply group Medical, Dental, And Veterinary Equipment And Supplies.
Tolterodine Tartrate is the active ingredient in these capsules, and it is primarily used to treat symptoms of an overactive bladder, such as frequent urination, urgency to urinate, and incontinence (involuntary leakage of urine).
The extended-release formulation of the capsules allows for a slow and controlled release of the medication over a certain period of time, providing continuous relief from the symptoms throughout the day.
These capsules are typically prescribed by healthcare professionals and should be taken as directed. It is important to follow the instructions provided by your healthcare provider and to not exceed the recommended dosage.
As with any medication, there may be potential side effects associated with Tolterodine Tartrate Extended-Release Capsules. Common side effects may include dry mouth, constipation, blurred vision, dizziness, and headache. If you experience any severe or persistent side effects, it is important to consult with your healthcare provider.
Please note that this information is for informational purposes only and should not replace the advice of a healthcare professional.
Related Item Names for INC 67495 Tolterodine Tartrate Extended-Release Capsules
NATO Stock Numbers with Item Name 67495 Tolterodine Tartrate Extended-Release Capsules Page 1 of 1
- DETROL LA
- RNCC: 5 | RNVC: 1 | DAC: 4
- DETRUSITOL LA 2MG CAPSULA
- RNCC: 3 | RNVC: 2 | DAC: 6